R&D News | pharmaphorum

News

Ex-Novartis CMO John Tsai joins Daiichi Sankyo

Daiichi Sankyo has named John Tsai as its new global head of R&D, replacing Ken Takeshita, who is stepping down after five years in the role.

News

MSD and Mayo Clinic team up on AI drug discovery

MSD has signed an industry-first deal with the Mayo Clinic that will allow it to use the health system's genomic and clinical data for drug discovery.

News

Number of UK biotech companies rising, says report

A report has found that the number of life sciences companies domiciled in the UK has grown by nearly a quarter in the last few years.

News

Novartis' oral BTK drug moves the needle in CINDU

Novartis is set to expand the label for its oral BTK inhibitor Rhapsido, keeping the drug on course to become one of its biggest-ever brands.

News

NHS study will pick apart mental illness with data science

Volunteers with schizophrenia, bipolar, and depression will take part in an NHS study that will use genetic and health data to find new therapies.

News

Compass points to strong psilocybin data in depression

Armed with new data, Compass wants to talk to the FDA about filing its psilocybin therapy COMP360 for approval in treatment-resistant depression.

Ex-Novartis CMO John Tsai joins Daiichi Sankyo

MSD and Mayo Clinic team up on AI drug discovery

Number of UK biotech companies rising, says report

Novartis' oral BTK drug moves the needle in CINDU

NHS study will pick apart mental illness with data science

Compass points to strong psilocybin data in depression

Zuckerberg, Chan's Biohub launches protein 'world model'

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks